Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
dfusion, a team of scientists and innovators, develops technology to promote evidence-based, health-related behavioral changes.
Vibrato Medical is a medical device company developing wearable treatments for peripheral arterial disease.
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight.
Greenstone Biosciences is a drug discovery platform that accelerates the development of effective therapies for patients.
Nexilico is an early-stage startup developing predictive computational platforms for gut microbiome precision medicine.
Epynomous app motivates teens and young adults ages 14-25 to undertake career exploration in a fresh, new way.
Mi-Helper helps to develop a non-drug remedy for migraine and mood issues.
WindGap Medical is a biotech company that manufactures medical devices used to treat patients with severe allergies.
Diagmetrics is a provider of mask-based diagnostic systems that aim to democratize testing and convert breath vapor into a fluid biosample.
Applied BioMath helps biotechnology and pharmaceutical companies accelerate and de-risk drug research and development.
Praxis Bioresearch is a biopharmaceutical company focused on the discovery and development of therapeutics for chronic neuropsychiatric.
iMetabolic Biopharma Corporation is a Biotechnology company.
Evoq Therapeutics is a cancer immunotherapy company that provides disease-specific immune modulators.
Reliant Glycosciences is a biotechnology company focused on developing diagnostic and prognostic tools for patients with IgA nephropathy.
Pioneering innovative biomedical technologies
Tabula Rasa enables medication optimization using its medication risk mitigation technology.
ID Genomics specializes in nucleotide sequence-based molecular diagnostics and epidemiologic analysis of microbial pathogens.
PediaMetrix brings AI and computer vision to pediatric health to lower cost and improve outcome.
Cell Microsystems develops, manufactures, and markets innovative products for single-cell biology.
Cerecor discovers, develops and commercializes neuroscience drugs.
Drug Discovery and Biotechnology
Reduce clinical variation and gain 10x efficiencies – continuous insights and monitoring
XLerateHealth is enterprise-focused and will help early stage healthcare companies build out their commercialisation strategy.
This company is a Boston-based biopharmaceutical company developing immune-based approaches.
National Institutes of Health has invested in 491 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institutes of Health's top investment sectors include Biotechnology, Health Care, Medical, Medical Device, Therapeutics. The firm invests across 26 different industry categories.
Among tracked funding rounds, Windgap Medical received $39.2M in a Series B round. National Institutes of Health's total known invested capital is $2.6B.
National Institutes of Health's average investment size is $6.6M across its portfolio of 491 companies.
Recent National Institutes of Health portfolio additions include dfusion, Vibrato Medical, Nanoscope Therapeutics, Greenstone Biosciences, Nexilico. These companies were founded in 2020 or later.